S-TARget Therapeutics

S-TARget therapeutics develops therapeutic vaccines to cure and prevent severe allergic diseases.

S-TARget therapeutics GmbH is a biotech start-up company founded in September 2010, that develops novel therapeutic vaccines to cure and prevent allergic diseases.

S-TARget‘s vaccines are based on the human specific, unique, proprietary S-TIR™ technology platform that addresses the cause of the disease not only the symptoms. The vaccines are directed against major, widespread allergic diseases that currently cannot be cured – including severe forms of allergy. Lead candidate SG100 targets allergic asthma induced by house dust mite (HDM), the major cause of allergy in the Western world.

S-TARget Therapeutics
Mooslackengase 17
1190 Wien

Telefon
+4369918904206

E-Mail
geert.mudde@s-target.com

Website
http://www.s-target.com

  • Start-Up Search

  • NEWSLETTER

  • Über INiTS

    INiTS hat sich als Business-Inkubator das Ziel gesetzt, die Erfolgswahrscheinlichkeit von Startups im Raum Wien zu erhöhen. Dabei unterstützt INiTS JungunternehmerInnen dabei, ihre Ideen in ein wachstumsstarkes und erfolgreiches Unternehmen umzusetzen. more

© INiTS Universitäres Gründerservice Wien GmbH, eine Gesellschaft von:

  • Logo TU Wien
  • Logo Uni Wien

Gefördert von:

  • Logo Wirtschaftsagentur
  • Logo FFG